Clinicopathological parameters in relation to p34cdc2 expression in nuclei of benign breast tissue (p34cdc2bn)
| p34cdc2bn expression | p Value | ||
|---|---|---|---|
| <10% | ⩾10% | ||
| ER, oestrogen receptor; p34cdc2TC, p34cdc2 expression in tumour cytoplasm; p34cdc2TN, p34cdc2 expression in tumour nuclei; PR, progesterone receptor. | |||
| Age (years) | |||
| <50 | 26 | 5 | |
| ⩾50 | 36 | 7 | 0.986 |
| Menopausal | |||
| Pre | 23 | 5 | |
| Post | 38 | 6 | 0.633 |
| T size | |||
| T1 | 30 | 7 | |
| T2 | 32 | 5 | 0.535 |
| Grade | |||
| 1 | 16 | 1 | |
| 2 | 25 | 6 | |
| 3 | 21 | 5 | 0.293 |
| p34cdc2TN | |||
| <10% | 11 | 1 | |
| ⩾10% | 51 | 11 | 0.425 |
| p34cdc2TC | |||
| <10% | 24 | 2 | |
| ⩾10% | 36 | 10 | 0.128 |
| p53 | |||
| <10% | 46 | 10 | |
| ⩾10% | 13 | 2 | 0.683 |
| p21WAF1 | |||
| <6% | 30 | 6 | |
| ⩾6% | 32 | 6 | 0.920 |
| ER | |||
| Negative | 25 | 5 | |
| Positive | 37 | 6 | 0.754 |
| PR | |||
| Negative | 32 | 4 | |
| Positive | 30 | 8 | 0.252 |
| Relapse | |||
| No | 54 | 11 | |
| Yes | 8 | 1 | 0.663 |
| Death | |||
| No | 57 | 11 | |
| Yes | 5 | 1 | 0.976 |